Whether you're a founder, CEO, or executive navigating complexity in 2025, the Business & Leadership Accelerator (BLA) ...

Pakistan’s internal crisis has escalated to the point where its territorial integrity is being questioned, with Balochistan’s ...

The Baloch liberation movement, one of South Asia's longest-running yet underreported conflicts, reflects a centuries-old ...

CNN-News18 decodes Pakistan’s escalating proxy war in Balochistan, where military-backed death squads have been empowered to ...

India changed the course of South Asian history. By supporting the liberation of East Pakistan, we gave birth to Bangladesh — ...

Discover key insights from Omeros Corporation's Q1 2025 earnings call. Learn about narsoplimab launch readiness, debt reduction, and FDA approval timelines.

Kathy Griffin accused Stephen Colbert of misogyny, calling him a 'dick' while alleging he made her cry during a 2017 'Late Show' interview about her infamous Trump photo: 'He came for me.' ...

The Baloch Liberation Army (BLA) has claimed the responsibility of killing 14 soldiers of Pakistan Army during their ongoing ...

Just two months after Inozyme Pharma Inc. cut its workforce by 25% and prioritized activities to focus on a BLA filing for INZ-701 for ENPP1 deficiency, interim phase III data from its Energy 3 trial ...

The FDA will issue a decision on the BLA for RGX-121 by November, which if positive, could make it the first gene therapy for Hunter syndrome.

Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2.

Discover REGENXBIO's Q1 2025 milestones, including FDA updates, pivotal trial progress, and commercial readiness for gene therapies addressing rare ...